Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)
Introduction: The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for Glomerulonephritis recommend that patients with membranous nephropathy (MN) at risk for progression receive immunosuppressive therapy (IST), usually after 6 months of observation. A cyclophospha...
Main Authors: | Michelle M. O’Shaughnessy, Jonathan P. Troost, Andrew S. Bomback, Michelle A. Hladunewich, Isa F. Ashoor, Keisha L. Gibson, Raed Bou Matar, David T. Selewski, Tarak Srivastava, Michelle N. Rheault, Amira Al-Uzri, Amy J. Kogon, Myda Khalid, Suzanne Vento, Neil S. Sanghani, Brenda W. Gillespie, Debbie S. Gipson, Chia-shi Wang, Afshin Parsa, Lisa Guay-Woodford, Louis-Philippe Laurin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919314834 |
Similar Items
-
Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network
by: Brenda W. Gillespie, et al.
Published: (2021-06-01) -
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study
by: Shannon L. Murphy, et al.
Published: (2020-10-01) -
Cardiac Angiosarcoma-Associated Membranoproliferative Glomerulonephropathy
by: Lokesh Shahani, et al.
Published: (2011-01-01) -
NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic Syndrome
by: Debbie S. Gipson, et al.
Published: (2018-03-01) -
Cure/Repeat/Cure
by: Lograsso, Anthony
Published: (2019)